| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3852204 | American Journal of Kidney Diseases | 2007 | 14 Pages |
Abstract
In patients with diabetes with mild to moderate anemia and moderate left ventricular hypertrophy, correction to an Hb target level of 13 to 15 g/dL (130 to 150 g/L) does not decrease LVMI. However, normalization of Hb level prevented an additional increase in left ventricular hypertrophy, was safe, and improved quality of life.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eberhard MD, PhD, Maurice MD, PhD, Rudy W. MD, PhD, Donal MD, PhD, Armin MD, Ulrich PhD, Fernando MD, PhD, ACORD Investigators and Coordinators ACORD Investigators and Coordinators,